Why is this important?
This measure will help reduce the number of severe hypoglycaemic events and improve blood glucose control in people with poor glycaemic awareness or suboptimal glycaemic control. Better control of blood sugar helps reduce long term complications of diabetes.
It will also help reduce visits to emergency departments and missed school days by allowing children and their families to better manage their type 1 diabetes as well as reduce anxiety for children and their parents.
This measure delivers on the Government’s election commitment to provide $54 million over five years to subsidise access to CGM technology.
Who will benefit?
Subsidised access to this technology will enable children and young adults under 21 years with type 1 diabetes who have impaired awareness of blood glucose levels to better manage their condition.
How much will this cost?
This measure will cost $54 million from 2016–17 to 2020–21.